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1 regulatory T cells (Tregs) are critical for the maintenance of immune tolerance by suppressing immune cell functions. In the context of infection such as Mycobacterium tuberculosis, Tregs can also suppress efficient protective immune responses against the pathogen and its effective clearance [1] . Results from studies of patients with tuberculosis and experimental models have shown that Tregs are expanded and accumulated at the site of infection. These Tregs efficiently inhibit the arrival of effector T cells in the lungs, production of interferon (IFN)-c and cd T-cell responses to M. tuberculosis [2] [3] [4] . However, mechanisms underlying the expansion of Tregs are not clear.
Periasamy et al [5] identified that Treg expansion by M. tuberculosis requires expression of the protein programmed death-1 (PD-1, CD279 
1 Tregs was analyzed using flow cytometry (LSR II, BD Biosciences). Surface staining was performed with fluorochrome-conjugated monoclonal antibodies (MAbs) to CD4 and CD25 (BD Biosciences), and intracellular staining for FoxP3 was performed using fluorochrome-conjugated MAb to FoxP3 and kit from eBioscience. We found that M. tuberculosis-treated DCs significantly expand Tregs (3.5% 6 0.5% in control vs 6.6% 6 0.8% in M. tuberculosis-treated DCs; n 5 5; Figure 1A ). The results suggest that the Treg expansion observed by Periasamy et al [5] was indeed attributable to modulation of DC (or innate immune cells in general) functions by M. tuberculosis.
We then attempted to identify the mechanisms by which M. tuberculosistreated DCs expand Tregs. Periasamy et al [5] identified PD-1 on Tregs as a key molecule involved in Treg expansion, indicating that molecules of PD-1 axis are implicated in Treg expansion by M. tuberculosis-treated DCs. Therefore, we analyzed the expression of PD-1 and its ligands PD-L1 (CD274) and PD-L2 (CD273) on DCs after stimulation with WCLs. The expression of these molecules were analyzed by flow cytometry by using the fluorochrome-conjugated MAbs (BD Biosciences). As shown in Figure 1B , M. tuberculosis selectively induced PD-L1 on DCs (12.4% 6 1.2% in controls vs 78.86% 6 12.8% in M. tuberculosistreated DCs; n 5 6), although the expression of PD-L2 and PD-1 were not altered. In fact, the expression of these molecules was either absent or negligible.
How does M. tuberculosis induce PD-L1 expression on DCs? DCs express a wide range of pattern recognition receptors, including lectin receptors and Toll-like receptors (TLRs), through which M. tuberculosis can interact and deliver signals [4] . We found that TLR2 and Ctype lectin receptor DC-SIGN, but not mannose receptor, have a major role in the induction of PD-L1 ( Figure 1C and data not shown). Blocking of both TLR2 and DC-SIGN appears to have an additive effect on reduction of PD-L1 on DCs, suggesting that both these receptors participate in the induction of PD-L1 on DCs after stimulation with M. tuberculosis. [5] , provide insight on how the Tregs are expanded. Two possibilities, however, can account for the Treg expansion. First, M. tuberculosis modulates antigen-presenting cells, leading to secretion of chemokines, such as CCL22 and CCL17, which attract Tregs to the site of infection. Furthermore, interaction of PD-L1 on the modulated antigen-presenting cells with PD-1 leads to expansion of migrated Tregs. Second, Tregs can also be generated (induced Tregs) and expanded from the infiltrated CD4
1 T cells at the site of infection via PD-L1 and PD-1 interaction. Indeed, the PD-L1 and PD-1 signaling pathway has been shown to be important for the generation of induced Tregs by DCs [6] . Therefore, molecules that target migration of Tregs and PD-1-PD-L1 pathway might have use in vaccination and therapy of tuberculosis [7] [8] [9] [10] .
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